Vascular dementia
Vascular dementia (VD) is a type of clinical mental disorder caused by vascular disease, and is also a type of clinical outcome of cerebrovascular disease. Cerebrovascular dementia or vascular dementia (VD) refers to a comprehensive decline in intelligence caused by cerebral blood supply disorders due to cerebrovascular disease. That is, a brain function degeneration disease caused by cerebrovascular disease with dementia as the main clinical manifestation. It often starts at the age of 50 to 60, and about half of them are complicated by primary hypertension, with a step-by-step deterioration of intelligence. Cerebrovascular dementia is more common in patients with repeated "mini-strokes", and the condition gradually worsens with each "mini-stroke". Intellectual decline is not progressive, but develops in a step-by-step manner. After the recovery of the "mini-stroke", the intelligence has recovered to a certain extent and the condition is stable; however, after another "mini-stroke", the attack worsens again, developing intermittently, and finally dementia occurs.
Related Drugs
Cerebroprotein Hydrolysate Injection
Indication: -Primary dementia (such as Alzheimer's type senile dementia). -Vascular dementia (such as multi-infarct dementia, etc.) and cognitive dysfunction after mild or moderate stroke. -Mixed dementia. -Improvement of brain dysfunction after craniocerebral injury.
Manufacturer:
Shanghai Huayuan Pharmaceutical (Ningxia) Shasai Pharmaceutical Co., Ltd.
Cerebroprotein Hydrolysate Injection
Indication: -Primary dementia (such as Alzheimer's type senile dementia). -Vascular dementia (such as multi-infarct dementia, etc.) and cognitive dysfunction after mild or moderate stroke. -Mixed dementia. -Improvement of brain dysfunction after craniocerebral injury.
Cerebroprotein Hydrolysate Injection
Indication: -Primary dementia (such as Alzheimer's type senile dementia). -Vascular dementia (such as multi-infarct dementia, etc.) and cognitive dysfunction after mild or moderate stroke. -Mixed dementia. -Improvement of brain dysfunction after craniocerebral injury.
Manufacturer:
Hebei Zhitong Biopharmaceutical Co., Ltd.
Cerebroprotein Hydrolysate Injection
Indication: -Primary dementia (such as Alzheimer's type senile dementia). -Vascular dementia (such as multi-infarct dementia, etc.) and cognitive dysfunction after mild or moderate stroke. -Mixed dementia. -Improvement of brain dysfunction after craniocerebral injury.
Manufacturer:
Guangdong Sunho Pharmaceutical Co., Ltd.
Dihydroergoline Mesylate Tablets
Indication: (1) Mainly used to improve the symptoms and physical signs of mental degeneration related to aging. (2) Symptoms of functional and intellectual decline caused by acute and chronic cerebrovascular diseases. (3) Mild to moderate vascular dementia. (4) Vascular headache.
Dihydroergoline Mesylate Tablets
Indication: (1) Mainly used to improve the symptoms and physical signs of mental degeneration related to aging. (2) Symptoms of functional and intellectual decline caused by acute and chronic cerebrovascular diseases. (3) Mild to moderate vascular dementia. (4) Vascular headache.
Aniracetam Capsules
Indication: 1. Vascular dementia and Alzheimer's disease with mild to moderate learning, memory and cognitive dysfunction. 2. Mild to moderate cognitive and behavioral disorders after stroke. 3. Benign memory impairment in the middle-aged and elderly.
Manufacturer:
Wuxi Cathy Pharmaceuticals Ltd.
Aniracetam Capsules
Indication: 1. Vascular dementia and Alzheimer's disease with mild to moderate learning, memory and cognitive dysfunction. 2. Mild to moderate cognitive and behavioral disorders after stroke. 3. Benign memory impairment in middle-aged and elderly people.
Manufacturer:
Guangdong Annuo Pharmaceutical Co., Ltd.
Aniracetam Capsules
Indication: 1. Vascular dementia and Alzheimer's disease with mild to moderate learning, memory and cognitive dysfunction. 2. Mild to moderate cognitive and behavioral disorders after stroke. 3. Benign memory impairment in middle-aged and elderly people.
Manufacturer:
Wuxi Kaifu Pharmaceutical Co., Ltd.
Aniracetam Capsules
Indication: Used for memory loss in middle-aged and elderly people and memory loss after cerebrovascular disease.
Manufacturer:
Guangdong Annuo Pharmaceutical Co., Ltd.